Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%

Reuters2025-10-23

Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%

Utah Medical Products Inc. reported financial results for the third quarter and first nine months of 2025. For the third quarter, revenues declined by 2% compared to the same period in 2024, and gross profit decreased by 3%. Operating income was down 22%. Income before tax fell by 21%, and net income declined by 26%. For the first nine months of 2025, revenues dropped by 7% compared to the previous year period, with gross profit down by 11%. Operating income decreased by 16%. Income before tax declined by 17%, and net income was down 21%. As of September 30, 2025, stockholders' equity was $118.3 million, compared to $117.5 million at the end of the previous quarter and $117.4 million as of September 30, 2024. Total liabilities and stockholders' equity were $122.0 million at the end of the third quarter of 2025, compared to $120.8 million at the end of the previous quarter and $122.5 million a year earlier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1090893) on October 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2577020683?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 21:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577020683","market":"fut","top_or_hot":-1,"title":"Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Utah Medical Products Inc. reported financial results for the third quarter and first nine months of 2025. For the third quarter, revenues declined by 2% compared to the same period in 2024, and gross profit decreased by 3%. Operating income was down 22%. Income before tax fell by 21%, and net income declined by 26%. For the first nine months of 2025, revenues dropped by 7% compared to the previous year period, with gross profit down by 11%. Operating income decreased by 16%. Income before tax declined by 17%, and net income was down 21%. As of September 30, 2025, stockholders' equity was $118.3 million, compared to $117.5 million at the end of the previous quarter and $117.4 million as of September 30, 2024. Total liabilities and stockholders' equity were $122.0 million at the end of the third quarter of 2025, compared to $120.8 million at the end of the previous quarter and $122.5 million a year earlier.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1090893) on October 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUtah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-23 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Utah Medical Products Inc. reported financial results for the third quarter and first nine months of 2025. For the third quarter, revenues declined by 2% compared to the same period in 2024, and gross profit decreased by 3%. Operating income was down 22%. Income before tax fell by 21%, and net income declined by 26%. For the first nine months of 2025, revenues dropped by 7% compared to the previous year period, with gross profit down by 11%. Operating income decreased by 16%. Income before tax declined by 17%, and net income was down 21%. As of September 30, 2025, stockholders' equity was $118.3 million, compared to $117.5 million at the end of the previous quarter and $117.4 million as of September 30, 2024. Total liabilities and stockholders' equity were $122.0 million at the end of the third quarter of 2025, compared to $120.8 million at the end of the previous quarter and $122.5 million a year earlier.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1090893) on October 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nNDLHlrVW:1","article_id":"2577020683","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577020683","pubTimestamp":1761224475,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Utah Medical Products Inc. reported financial results for the third quarter and first nine months of 2025. For the third quarter, revenues declined by 2% compared to the same period in 2024, and gross profit decreased by 3%. Operating income was down 22%. Income before tax fell by 21%, and net income declined by 26%. For the first nine months of 2025, revenues dropped by 7% compared to the previous year period, with gross profit down by 11%. Operating income decreased by 16%. Income before tax declined by 17%, and net income was down 21%. As of September 30, 2025, stockholders' equity was $118.3 million, compared to $117.5 million at the end of the previous quarter and $117.4 million as of September 30, 2024. Total liabilities and stockholders' equity were $122.0 million at the end of the third quarter of 2025, compared to $120.8 million at the end of the previous quarter and $122.5 million a year earlier.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","UTMD":"犹他医疗产品"},"translate_title":"犹他医疗产品公司报告2025年第三季度销售额下降2%，净利润下降26%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UTMD":0.9},"content_text":"Utah Medical Products Inc. Reports 3Q 2025 Sales Down 2% and Net Income Down 26%\n    \n\n        Utah Medical Products Inc. reported financial results for the third quarter and first nine months of 2025. For the third quarter, revenues declined by 2% compared to the same period in 2024, and gross profit decreased by 3%. Operating income was down 22%. Income before tax fell by 21%, and net income declined by 26%. For the first nine months of 2025, revenues dropped by 7% compared to the previous year period, with gross profit down by 11%. Operating income decreased by 16%. Income before tax declined by 17%, and net income was down 21%. As of September 30, 2025, stockholders' equity was $118.3 million, compared to $117.5 million at the end of the previous quarter and $117.4 million as of September 30, 2024. Total liabilities and stockholders' equity were $122.0 million at the end of the third quarter of 2025, compared to $120.8 million at the end of the previous quarter and $122.5 million a year earlier.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1090893) on October 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577020683","isCrawlerRequest":true}